Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: Discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach-Reference-Cited by-同舟云学术

Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: Discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach

Published:2014-10 Issue: Volume:85 Page:293-303
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Liu,Tian Ye,Chen Wenmin,Liu Hong,Zhan Peng,Li Dongyue,Liu Huiqing,De Clercq Erik,Pannecouque Christophe,Liu Xinyong

Funder

National Natural Science Foundation of China

Key Project of NSFC for International Cooperation

Research Fund for the Doctoral Program of Higher Education of China

Shandong Provincial Natural Science Foundation, China

KU Leuven

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference31 articles.

1. The design of drugs for HIV and HCV;De Clercq;Nat. Rev. Drug. Discov.,2007

2. Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005–2010);Zhan;Expert Opin. Ther. Patents,2011

3. Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006–2008 update;Zhan;Curr. Med. Chem.,2009

4. Recent advances in the discovery and development of novel HIV-1 NNRTI platforms (Part II): 2009–2013 update;Song;Curr. Med. Chem.,2013

5. Design strategies of novel NNRTIs to overcome drug resistance;Zhan;Curr. Med. Chem.,2009

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance;Medicinal Research Reviews;2024-08-26

2. 1,2,4-Triazolo-quinazolinones as Effective Antifoulants: Molecular Design, Synthesis, and Biological Evaluation;Langmuir;2024-07-16

3. Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells;Bioorganic Chemistry;2023-09

4. Diarylpyrimidines and related analogs as antiviral agents;Privileged Scaffolds in Drug Discovery;2023

5. An Overview on Synthetic and Medicinal Perspectives of [1,2,4]Triazolo[1,5‐ a ]pyrimidine Scaffold;Chemistry & Biodiversity;2022-08-10